| Revenue Recognition |
Revenue
by Service Line
| |
|
Three
Months Ended June 30, |
|
| |
|
2018 |
|
|
2017 |
|
| Products: |
|
|
|
|
|
|
| Disposable
products: |
|
|
|
|
|
|
|
|
| Functional
neurology |
|
$ |
1,159,527 |
|
|
$ |
1,343,425 |
|
| Biologics
and drug delivery |
|
|
111,792 |
|
|
|
92,479 |
|
| Capital
equipment |
|
|
141,280 |
|
|
|
456,734 |
|
| Total
product revenue |
|
|
1,412,599 |
|
|
|
1,892,638 |
|
| Services: |
|
|
|
|
|
|
|
|
| Capital
equipment and other |
|
|
71,736 |
|
|
|
83,367 |
|
| Biologics
and drug delivery |
|
|
162,000 |
|
|
|
- |
|
| Total
service revenue |
|
|
233,736 |
|
|
|
83,367 |
|
| Total
revenue |
|
$ |
1,646,335 |
|
|
$ |
1,976,005 |
|
| |
|
Six
Months Ended June 30, |
|
| |
|
2018 |
|
|
2017 |
|
| Products: |
|
|
|
|
|
|
| Disposable
products: |
|
|
|
|
|
|
|
|
| Functional
neurology |
|
$ |
2,338,862 |
|
|
$ |
2,931,867 |
|
| Biologics
and drug delivery |
|
|
292,258 |
|
|
|
167,486 |
|
| Capital
equipment |
|
|
320,078 |
|
|
|
715,500 |
|
| Total
product revenue |
|
|
2,951,198 |
|
|
|
3,814,853 |
|
| Services: |
|
|
|
|
|
|
|
|
| Capital
equipment and other |
|
|
156,504 |
|
|
|
168,224 |
|
| Biologics
and drug delivery |
|
|
162,000 |
|
|
|
- |
|
| Total
service revenue |
|
|
318,504 |
|
|
|
168,224 |
|
| Total
revenue |
|
$ |
3,269,702 |
|
|
$ |
3,983,077 |
|
|